Form 8-K - Current report:
SEC Accession No. 0001193125-21-214740
Filing Date
2021-07-14
Accepted
2021-07-14 09:19:59
Documents
7
Period of Report
2021-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d138853d8k.htm 8-K 21952
2 EX-1.1 d138853dex11.htm EX-1.1 168002
3 EX-5.1 d138853dex51.htm EX-5.1 11569
4 EX-99.1 d138853dex991.htm EX-99.1 7732
5 EX-99.2 d138853dex992.htm EX-99.2 7946
6 GRAPHIC g138853dsp46_footer.jpg GRAPHIC 6635
7 GRAPHIC g138853dsp46_logo.jpg GRAPHIC 1686
  Complete submission text file 0001193125-21-214740.txt   230120
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 211089361
SIC: 2834 Pharmaceutical Preparations